MARKET RADAR
SENSEX     NIFTY      Refresh
GlaxoSmithKline Pharmaceuticals Consolidated Cash Flow, GlaxoSmithKline Pharmaceuticals Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Cash Flow - GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals
BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 28, 17:00
2003.30
12.55 (0.63%)
VOLUME 4,920
LIVE
NSE
May 28, 17:00
2004.80
9.75 (0.49%)
VOLUME 3,876

Consolidated Cash Flow of GlaxoSmithKline Pharmaceuticals

------------------- in Rs. Cr. -------------------
Dec '11 Dec '10 Dec '09 Dec '08 Dec '07
12 mths 12 mths 12 mths 12 mths 12 mths
Net Profit Before Tax 927.33 871.62 761.16 701.01 627.53
Net Cash From Operating Activities 335.64 479.36 511.51 330.03 318.83
Net Cash (used in)/from
Investing Activities
99.22 86.76 660.78 826.92 98.86
Net Cash (used in)/from Financing Activities -394.81 -297.15 -394.84 -355.34 -298.49
Net (decrease)/increase In Cash and Cash Equivalents 40.05 268.97 777.45 801.61 119.20
Opening Cash & Cash Equivalents 2003.01 1734.03 956.58 154.97 35.77
Closing Cash & Cash Equivalents 2043.06 2003.01 1734.03 956.58 154.97
Source : Dion Global Solutions Limited
Quick Links for glaxosmithklinepharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.